Cardinal Health Recalls Steglatro Tablets Due to Temperature Excursions
Cardinal Health is recalling 215 bottles of Steglatro (ertugliflozin) 15 mg tablets due to intermittent temperature excursions during storage.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically indicates a reasonable probability of temporary or medically reversible health consequences. The hazard involves storage conditions (temperature excursions) rather than a confirmed contamination or defect causing immediate harm, fitting the Moderate severity criteria for potential quality issues without reported injuries.
Plain-English summary
Cardinal Health Inc. is recalling 215 bottles of Steglatro (ertugliflozin) 15 mg tablets, 30-count bottles. The product was distributed in Florida, Georgia, and South Carolina. The recall is due to CGMP deviations involving intermittent exposure to temperature excursions during storage.
The affected product is identified by lot code T013566. Steglatro is a prescription oral medication manufactured for Merck Sharp & Dohme Corp. The recall is classified as Class II by the FDA.
Consumers with this product should contact their healthcare provider or pharmacist for guidance on whether to discontinue use or obtain a replacement.
The recalled product
- Product
- STEGLATRO (ERTUGLIFLOZIN)
- Brand
- STEGLATRO
- Manufacturer
- Cardinal Health Inc.
- Category
- Drug — Prescription Medication
- Affected units
- 215
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- T013566
UPCs (2)
- 0300065363035
- 0300065364032
Distribution
Part of a larger recall action
This product is one of 198 recalled by Cardinal Health Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 198 products in this recall →Related recalls
Same manufacturer · Cardinal Health Inc.
See all →- HighEnoxaparin syringe bags recalled after being labeled with the wrong strength
FDA (Drugs) · 2025-09-03
- ModerateXolair auto-injectors exposed to temperatures outside labeled storage requirements
FDA (Drugs) · 2025-08-13
- ModerateRecombinate antihemophilic factor vials exposed to temperatures outside labeled storage
FDA (Drugs) · 2025-08-13
- ModerateXolair 75 mg syringes exposed to temperatures outside labeled storage requirements
FDA (Drugs) · 2025-08-13
- ModerateWegovy injection recalled due to temperature exposure during shipping
FDA (Drugs) · 2025-05-07
Same hazard · temperature excursion
See all →- ModerateCyclophosphamide injection vials recalled after a transportation temperature excursion
FDA (Drugs) · 2025-09-24
- ModerateProlia prefilled syringes recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateBenlysta vials recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateEvenity prefilled syringes recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30